I find the comparable strength of some of the KOL anecdotes for $QURE and $TENX interesting to consider. The $TENX fail raises the question of whether we should give weight to the $QURE KOL anecdotes when the $TENX anecdotes proved to not carry predictive value. This question is
This is a good sign that safety is tracking as hoped so far for the 10mg / kg MAD cohort, particularly given 7/8 of 10mg / kg MAD patients have completed dosing, the eighth patient will have at least two of four doses under the belt.
If efficacy at 10mg / kg also goes the way I
